SORBENT REACTOR FOR EXTRACORPOREAL BLOOD TREATMENT SYSTEMS, PERITONEAL DIALYSIS SYSTEMS, AND OTHER BODY FLUID TREATMENT SYSTEMS
    2.
    发明申请
    SORBENT REACTOR FOR EXTRACORPOREAL BLOOD TREATMENT SYSTEMS, PERITONEAL DIALYSIS SYSTEMS, AND OTHER BODY FLUID TREATMENT SYSTEMS 审中-公开
    用于提取血液治疗系统,透析系统和其他身体液体治疗系统的吸附反应器(SORBENT REACTOR FOR EXTRACORPOREAL BLOOD TREATATION SYSTEMS,PERITONEAL DIALYSIS SYSTEMS)

    公开(公告)号:WO2004105589A3

    公开(公告)日:2005-06-23

    申请号:PCT/US2004017181

    申请日:2004-05-28

    Abstract: Systems and methods for extracorporeal processing of blood or other body fluid for the treatment of conditions, such as sepsis, autoimmune disease, or toxemia related to kidney failure, liver failure, or drug overdose are provided. In an extracorporeal treatment system (10, 180, and 250), a fraction of a body fluid is passed into a treatment fluid, at least a portion of which is then passed through a sorbent suspension reactor (34, 50, 90, 150, 200, 350, 400, 440, 170, and 480) for treatment by a sorbent suspension. The treatment fluid circuit (14, 184) can be maintained at a fixed volume, which enables accurate fluid balance between the patient and the extracorporeal circuit. Some or all of the treatment fluid, optionally also containing nutrients and/or therapeutic agents, is returned to the patient. In a peritoneal dialysis system, dialysate is passed into a patient's peritoneal cavity, recovered from the cavity, passed through a sorbent suspension reactor in accordance with the invention, and returned to the cavity.

    Abstract translation: 提供了用于治疗诸如败血症,自身免疫疾病或与肾功能衰竭,肝衰竭或药物过量相关的毒血症等病症的血液或其它体液的体外加工的系统和方法。 在体外治疗系统(10,180和250)中,将一部分体液通入治疗液体中,其中至少一部分体液然后通过吸附剂悬浮反应器(34,50,90,150, 200,350,400,440,170和480),用于通过吸附剂悬浮液进行处理。 治疗流体回路(14,184)可以保持在固定的体积,这使得患者和体外循环之间能够获得精确的流体平衡。 一些或全部处理液,任选地还含有营养物质和/或治疗剂,返回给患者。 在腹膜透析系统中,透析液通过病人的腹膜腔,从腔中回收,通过根据本发明的吸附剂悬浮反应器,并返回到腔中。

    CONDUCTIVITY DETECTOR FOR FLUIDS
    4.
    发明申请
    CONDUCTIVITY DETECTOR FOR FLUIDS 审中-公开
    流体传感器检测器

    公开(公告)号:WO2012037106A1

    公开(公告)日:2012-03-22

    申请号:PCT/US2011/051370

    申请日:2011-09-13

    CPC classification number: G01N27/07 G01R27/22

    Abstract: A conductivity detector detects the electrical conductivity of a fluid under analysis for determining chemical or physical properties of the fluid that are related its electrical properties. Such conductivity detectors may find use in, for example, hemodialysis systems for analyzing the effectiveness of the hemodialysis treatment. In an aspect, to improve accuracy of the conductivity measurements, the detector utilizes four-wire resistance measurement methods. In another aspect, to avoid fouling or contamination of the electrodes, the detector utilizes capacitively-coupled contactless conductivity detection (C4D) methods so that the electrodes are physically unconnected to the fluid contained in a fluid chamber. In a possible further aspect, the fluid chamber may be a disposable component removable from the electrodes. The conductivity detector can include other features such as calibration circuits and features for electrically isolating the fluid under detection from the fluid in the rest of the system.

    Abstract translation: 电导率检测器检测被分析的流体的电导率,以确定与其电性质相关的流体的化学或物理性质。 这种电导率检测器可用于例如用于分析血液透析治疗的有效性的血液透析系统。 在一方面,为了提高电导率测量的精度,检测器采用四线电阻测量方法。 在另一方面,为了避免电极的结垢或污染,检测器利用电容耦合的非接触式电导率检测(C4D)方法,使得电极物理上不与流体室中包含的流体相连。 在可能的另一方面,流体室可以是可从电极移除的一次性部件。 导电性检测器可以包括诸如校准电路和用于将检测中的流体与系统的其余部分中的流体电隔离的其它特征。

    SORBENT REACTOR FOR EXTRACORPOREAL BLOOD TREATMENT SYSTEMS, PERITONEAL DIALYSIS SYSTEMS, AND OTHER BODY FLUID TREATMENT SYSTEMS
    5.
    发明申请
    SORBENT REACTOR FOR EXTRACORPOREAL BLOOD TREATMENT SYSTEMS, PERITONEAL DIALYSIS SYSTEMS, AND OTHER BODY FLUID TREATMENT SYSTEMS 审中-公开
    超声波血液治疗系统的同位素反应器,腹膜透析系统和其他身体液体治疗系统

    公开(公告)号:WO2004105589A2

    公开(公告)日:2004-12-09

    申请号:PCT/US2004/017181

    申请日:2004-05-28

    IPC: A61B

    Abstract: Systems and methods for extracorporeal processing of blood or other body fluid for the treatment of conditions, such as sepsis, autoimmune disease, or toxemia related to kidney failure, liver failure, or drug overdose are provided. In an extracorporeal treatment system (10, 180, and 250), a fraction of a body fluid is passed into a treatment fluid, at least a portion of which is then passed through a sorbent suspension reactor (34, 50, 90, 150, 200, 350, 400, 440, 170, and 480) for treatment by a sorbent suspension. The treatment fluid circuit (14, 184) can be maintained at a fixed volume, which enables accurate fluid balance between the patient and the extracorporeal circuit. Some or all of the treatment fluid, optionally also containing nutrients and/or therapeutic agents, is returned to the patient. In a peritoneal dialysis system, dialysate is passed into a patient's peritoneal cavity, recovered from the cavity, passed through a sorbent suspension reactor in accordance with the invention, and returned to the cavity.

    Abstract translation: 提供了用于治疗诸如败血症,自身免疫疾病或与肾衰竭,肝衰竭或药物过量相关的毒血症的病症的血液或其它体液的体外加工的系统和方法。 在体外治疗系统(10,180和250)中,将一部分体液通入处理液体中,其中至少一部分体液然后通过吸附剂悬浮反应器(34,50,90,150, 200,350,400,440,170和480),用于通过吸附剂悬浮液进行处理。 治疗流体回路(14,184)可以保持在固定的体积,这使得患者和体外循环之间能够获得精确的流体平衡。 一些或全部治疗液,任选地还含有营养物和/或治疗剂,被返回给患者。 在腹膜透析系统中,透析液通过患者的腹膜腔,从腔中回收,通过根据本发明的吸附剂悬浮反应器,并返回到腔中。

Patent Agency Ranking